PHIO PHARMACEUTICALS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PHIO PHARMACEUTICALS CORP. (PHIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-03-31 was 2.00K shares, a 91.17% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-12-31 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 33.04K shares, a 43.59% decline from fiscal 2016.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 58.57K shares, a 85.54% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-05 | 0.00 shares 10-K · filed 2026-03-05 | |||||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 0.00 shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | |||||||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-05 | |||||||
| 2018-03-31 | 2.00K shares 10-Q · filed 2018-05-10 | 2.00K shares derived: sum of 2 quarters · filed 2018-05-10 | 2.20K shares derived: sum of 3 quarters · filed 2018-05-10 | 12.40K shares derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | 200.00 shares derived: sum of 2 quarters · filed 2018-03-26 | 10.40K shares derived: sum of 3 quarters · filed 2018-03-26 | 33.04K shares 10-K · filed 2018-03-26 | ||||
| 2017-09-30 | 200.00 shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-03-26 | 10.40K shares derived: sum of 2 quarters · filed 2018-03-26 | 33.04K shares 10-Q/A · filed 2018-03-26 | 330.38K shares 10-Q · filed 2017-11-08 | 33.04K shares derived: sum of 4 quarters · filed 2018-03-26 | |||
| 2017-06-30 | 10.20K shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-03-26 | 32.84K shares 10-Q/A · filed 2018-03-26 | 328.38K shares 10-Q · filed 2017-08-10 | 32.84K shares derived: sum of 3 quarters · filed 2018-03-26 | 33.84K shares derived: sum of 4 quarters · filed 2018-03-26 | |||
| 2017-03-31 | 22.64K shares 10-Q/A · filed 2018-03-26 | 226.38K shares 10-Q · filed 2017-05-11 | 22.64K shares derived: sum of 2 quarters · filed 2018-03-26 | 23.64K shares derived: sum of 3 quarters · filed 2018-03-26 | 23.64K shares derived: sum of 4 quarters · filed 2018-03-26 | |||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 1.00K shares derived: sum of 2 quarters · filed 2017-03-30 | 1.00K shares derived: sum of 3 quarters · filed 2018-03-26 | 58.57K shares 10-K · filed 2017-03-30 | ||||
| 2016-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 1.00K shares derived: sum of 2 quarters · filed 2018-03-26 | 58.57K shares 10-Q · filed 2016-11-10 | 73.57K shares derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2016-06-30 | 0.00 shares 10-Q/A · filed 2018-03-26 | 57.57K shares 10-Q · filed 2016-08-11 | 72.57K shares derived: sum of 3 quarters · filed 2018-03-26 | 108.07K shares derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2016-03-31 | 57.57K shares 10-Q · filed 2016-05-12 | 72.57K shares derived: sum of 2 quarters · filed 2016-05-12 | 108.07K shares derived: sum of 3 quarters · filed 2016-05-12 | 383.73K shares derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2015-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 50.50K shares derived: sum of 2 quarters · filed 2016-03-30 | 326.16K shares derived: sum of 3 quarters · filed 2016-03-30 | 405.16K shares 10-K · filed 2016-03-30 | ||||
| 2015-09-30 | 35.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 311.16K shares derived: sum of 2 quarters · filed 2015-11-12 | 390.16K shares 10-Q · filed 2015-11-12 | 403.16K shares derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2015-06-30 | 275.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 354.66K shares 10-Q · filed 2015-08-12 | 367.66K shares derived: sum of 3 quarters · filed 2015-08-12 | 426.00K shares derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2015-03-31 | 79.00K shares 10-Q · filed 2015-05-13 | 92.00K shares derived: sum of 2 quarters · filed 2015-05-13 | 150.33K shares derived: sum of 3 quarters · filed 2015-05-13 | 498.00K shares derived: sum of 4 quarters · filed 2015-05-13 | ||||
| 2014-12-31 | 13.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | 71.33K shares derived: sum of 2 quarters · filed 2015-03-30 | 419.00K shares derived: sum of 3 quarters · filed 2015-03-30 | 444.00K shares 10-K · filed 2015-03-30 | ||||
| 2014-09-30 | 58.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 406.00K shares derived: sum of 2 quarters · filed 2014-11-13 | 431.00K shares 10-Q · filed 2014-11-13 | 431.00K shares derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2014-06-30 | 347.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | 372.66K shares 10-Q · filed 2014-08-14 | 372.66K shares derived: sum of 3 quarters · filed 2014-08-14 | 382.67K shares derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2014-03-31 | 25.00K shares 10-Q · filed 2014-05-14 | 25.00K shares derived: sum of 2 quarters · filed 2014-05-14 | 35.00K shares derived: sum of 3 quarters · filed 2014-05-14 | |||||
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | 10.00K shares derived: sum of 2 quarters · filed 2014-03-28 | 430.00K shares 10-K · filed 2014-03-28 | |||||
| 2013-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 430.00K shares 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | 420.00K shares 10-Q · filed 2013-08-14 | |||||||
| 2012-12-31 | -61.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -60.97M shares derived: sum of 2 quarters · filed 2014-03-28 | 2.13M shares 10-K · filed 2014-03-28 | 63.85M shares 10-K · filed 2013-03-29 | ||||
| 2012-09-30 | 750.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | 63.85M shares 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | 63.10M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |